Latest pharma updates on New Developments

NEC, JFCR & Taiho to Develop Shared-Neoantigen Cancer Vaccines

NEC, together with the Japan Cancer Research Institute (JFCR) and Taiho Pharmaceutical, publicized a partnership to crea...

Read Full Story

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.